Jefferies analyst Benjamin Jackson CFA maintained a Sell rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded ...

J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and ...

The chief executives of several pharmaceutical giants based in Ireland, such as Pfizer, Eli Lilly, and MSD, said there was a ...

Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. | ...

The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...

Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...

Despite missing a phase II study’s primary endpoint in moderate to severe asthma, Sanofi SA sees a way forward to a phase III program in the crowded disease space. Preliminary results showed the ...